TUSTIN, CA: Radient Pharmaceuticals Corporation, a developer of in vitro diagnostic cancer tests, has hired Dilek Mir as director of investor relations and business development.
In addition to IR and business development, Mir will also oversee new business, reimbursement strategy, and intellectual property strategy. Her IR experience spans 13 years, having advised and represented a number of publicly traded technology and healthcare companies. Mir also founded Polygot International, a privately owned language training firm in Moscow.